sorafenib has been researched along with clobetasol in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (clobetasol) | Trials (clobetasol) | Recent Studies (post-2010) (clobetasol) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,532 | 389 | 593 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Betlloch, I; Cuesta, L; Latorre, N; Monteagudo, A; Toledo, F | 1 |
| Pathania, YS | 1 |
2 other study(ies) available for sorafenib and clobetasol
| Article | Year |
|---|---|
Severe sorafenib-induced hand-foot skin reaction.
Topics: Antineoplastic Agents; Benzenesulfonates; Bone Neoplasms; Carcinoma, Hepatocellular; Clobetasol; Disease Progression; Drug Eruptions; Fatal Outcome; Foot Dermatoses; Hand Dermatoses; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib | 2011 |
Hand-foot skin reaction induced by sorafenib in a hepatocellular carcinoma patient.
Topics: Administration, Topical; Adrenal Cortex Hormones; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Clobetasol; Drug Tapering; Enzyme Inhibitors; Hand-Foot Syndrome; Humans; Liver Neoplasms; Male; Sorafenib; Treatment Outcome | 2020 |